Quoted Micro 15 May 2023
AQUIS STOCK EXCHANGE Third quarter revenues of National Milk Records (NMR) were 15% higher at £6.5m. The core milk testing revenues were 14% ahead, helped by price rises. Genomic testing revenues more than doubled. Milk prices have fallen, but they are still relatively high. Canaccord Genuity still expects a dip in 2023 pre-tax profit from […]
Quoted Micro 20 March 2023
AQUIS STOCK EXCHANGE MBH Corporation (LON: MBH) joined the Access segment of the Aquis Stock Exchange on 13 March. The shares have previously been traded on the Frankfurt Stock Exchange and the Dusseldorf Stock Exchange. Trading started on Aquis at 7p (5p/9p) and it stayed at that price all week. There were no trades. MBH […]
Quoted Micro 13 March 2023
AQUIS STOCK EXCHANGE Ananda Developments (ANA) is acquiring MRX Global, which has invented a method to formulate cannabis medicines, for £2.02m in shares at 0.3p each. The first formulation is MRX1, which will be used in two phase II randomised controlled trials to investigate the effectiveness of cannabidiol in chemotherapy induced peripheral neuropathy and in […]
Quoted Micro 6 March 2023
AQUIS STOCK EXCHANGE Invinity Energy Systems (IES) is repaying the remaining $2.1m of its $2.5m convertible loan facility provided by RiverFort Global Opportunities out of the proceeds of the recent placing. There is a 10% redemption premium, making the total cost £1.92m. That stops dilution by the issue of six million shares. Related warrants can […]
Quoted Micro 20 February 2023
AQUIS STOCK EXCHANGE EDX Medical Group (EDX) acquired Torax Biosciences for the issue of 1.67 million shares at a notional 6p each. Torax provides development and pilot scale fabrication of immunochemistry-based assays and diagnostic testing services. The experienced team at Torax was an attraction. Marula Mining (MARU) signed a co-development and relationship agreement with a […]
Quoted Micro 30 May 2022
AQUIS STOCK EXCHANGE Silverwood Brands (SLWD) has secured a deal to buy Balmonds Skincare, which manufactures products for people with skin conditions, such as eczema, psoriasis and dermatitis. The total cost of the acquisition will be up to £8m, all in shares, depending on achievement of performance criteria. A shareholder loan will also be acquired […]
Ian Pollard: Purplebricks Founder Leaves With Immediate Effect
Purplebricks Group plc PURP is pulling out of the Australian market and the Group’s Founder and Chief Executive Officer is falling on his sword and stepping down from the business with immediate effect. The Board admits that the company’s performance has been disappointing over the last 12 months and offers its sincere apologies to shareholders […]
Andrew Hore – Quoted Micro 12 November 2018
NEX EXCHANGE Crossword Cybersecurity (CCS) plans to raise up to £2.25m prior to a move to AIM at the end of this year. The cash will be invested in sales and marketing, product development and working capital. Primorus Investments (PRIM) says that investee company Stream TV Networks has secured a deal with Beijing Optical […]
Ian Pollard – Direct Line #DLG delivers a robust fall in premiums
Direct Line Ins. Group DLG claims to have delivered a robust third quarter performance in a competitive market. Robust in this particular case being defined as a fall of 5.6% in gross written premiums, compared to the same quarter in 2017, Perhaps this is a definition which not many outside the company could bring themselves […]
Andrew Hore – Quoted Micro 2 April 2018
NEX EXCHANGE Sativa Investments (SAPI) joined NEX on 29 March after raising £1.1m at 1p a share. The share price has already reached 3.125p. Sativa has £1.5m in cash that it can invest in businesses involved in medicinal cannabis. The initial focus is Canada. Capital for Colleagues (CFCP) reported a slight reduction in NAV […]